Rosuvastatin News and Research

RSS
FDA expands indication for Crestor

FDA expands indication for Crestor

AstraZeneca's CRESTOR receives favorable vote from FDA Advisory Committee

AstraZeneca's CRESTOR receives favorable vote from FDA Advisory Committee

High blood pressure: A major risk factor for stroke and heart disease

High blood pressure: A major risk factor for stroke and heart disease

Dual niacin-statin therapy improves blood cholesterol levels but does not diminish plaque buildup

Dual niacin-statin therapy improves blood cholesterol levels but does not diminish plaque buildup

CRESTOR reduces major cardiovascular events in women by 46%

CRESTOR reduces major cardiovascular events in women by 46%

Simcere Pharmaceutical announces financial results for the third quarter of 2009

Simcere Pharmaceutical announces financial results for the third quarter of 2009

Vanderbilt University researchers study role of statins in reducing flu-related deaths

Vanderbilt University researchers study role of statins in reducing flu-related deaths

Simcere Pharmaceutical Group signs agreement to acquire manufacturing license from Tianjin Tianda Pharmaceutical

Simcere Pharmaceutical Group signs agreement to acquire manufacturing license from Tianjin Tianda Pharmaceutical

AstraZeneca's CRESTOR approved for treating pediatric patients with HeFH

AstraZeneca's CRESTOR approved for treating pediatric patients with HeFH

Drug design: palladium catalyst used to attach fluorine atom to aromatic compounds

Drug design: palladium catalyst used to attach fluorine atom to aromatic compounds

NTRILIPIX (fenofibric acid) in combo with Rosuvastatin calcium shows improvement on key lipids for cholesterol management

NTRILIPIX (fenofibric acid) in combo with Rosuvastatin calcium shows improvement on key lipids for cholesterol management

CRESTOR found to reduced CV risk in patients achieving low LDL-C and hsCRP targets in new Jupiter analysis

CRESTOR found to reduced CV risk in patients achieving low LDL-C and hsCRP targets in new Jupiter analysis

CRESTOR (rosuvastatin) shown to significantly reduce risk of venous thromboembolism

CRESTOR (rosuvastatin) shown to significantly reduce risk of venous thromboembolism

Statins can stimulate cardiac muscle cell regeneration, improve heart function

Statins can stimulate cardiac muscle cell regeneration, improve heart function

Numerical analysis estimates numbers of older US adults who may benefit from statin therapy

Numerical analysis estimates numbers of older US adults who may benefit from statin therapy

Rosuvastatin trial shows dramatic reduction in hidden heart disease

Rosuvastatin trial shows dramatic reduction in hidden heart disease

Simple blood test for high-sensitivity C-reactive protein is a useful marker for cardiovascular disease

Simple blood test for high-sensitivity C-reactive protein is a useful marker for cardiovascular disease

Crestor (rosuvastatin calcium) shown to significantly reduce major cardiovascular events

Crestor (rosuvastatin calcium) shown to significantly reduce major cardiovascular events

Metabolic genes tied to inflammatory predictor of heart disease and stroke risk

Metabolic genes tied to inflammatory predictor of heart disease and stroke risk

Genomas awarded $1.2 million to develop DNA-guided system for management of statin therapy

Genomas awarded $1.2 million to develop DNA-guided system for management of statin therapy